A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

PHOENIX (AZFamily) — A ketamine-derived nasal spray is now available for the millions of Americans living with severe ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

The US FDA has approved the first of its kind ketamine-based nasal spray which is supposed to act as a standalone therapy for treatment-resistant depression.

Because it is still awaiting approval, Medicare does not typically cover the use of ketamine infusion for treating mental ...

The city of Vancouver’s emergency winter weather shelters are preparing for possible freezing temperatures this week. Washington County announced they will open their emergency warming shelters ...

Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven't responded to oral ...